Literature DB >> 26031709

Phenotypic and Molecular Evidence Suggests That Decrements in Morning and Evening Energy Are Distinct but Related Symptoms.

Bradley E Aouizerat1, Anand Dhruva2, Steven M Paul3, Bruce A Cooper3, Kord M Kober3, Christine Miaskowski4.   

Abstract

CONTEXT: Little is known about energy levels in oncology patients and their family caregivers.
OBJECTIVES: This study sought to identify latent classes of participants, based on self-reported energy levels and evaluate for differences in phenotypic and genotypic characteristics between these classes.
METHODS: Energy subscale scores from the Lee Fatigue Scale were used to determine latent class membership. Morning and evening energy scores were obtained just before, during, and for four months after the completion of radiation therapy. Genetic associations were evaluated for 15 proinflammatory and anti-inflammatory cytokine genes.
RESULTS: Two latent classes with distinct morning energy trajectories were identified. Participants who were younger, female, not married/partnered, black, and had more comorbidities, and a lower functional status were more likely to be in the low morning energy class. Two polymorphisms (IL2 rs1479923 and NFKB1 rs4648110) were associated with morning energy latent class membership. Two latent classes with distinct evening energy trajectories were identified. Participants who were younger and male and who had more comorbidities, decreased body weight, and a lower functional status were more likely to be in the moderate evening energy class. Five different polymorphisms (IL1R2 rs4141134, IL6 rs4719714, IL17A rs8193036, NFKB2 rs1056890, and TNFA rs1800683) were associated with evening energy latent class membership.
CONCLUSION: This study provides preliminary evidence that decrements in morning and evening energy are associated with different phenotypic risk factors and cytokine gene variations.
Copyright © 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Energy; cancer; cytokines; family caregivers; fatigue; growth mixture modeling; radiation therapy; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 26031709      PMCID: PMC4624028          DOI: 10.1016/j.jpainsymman.2015.05.008

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  76 in total

1.  The challenge of response shift for quality-of-life-based clinical oncology research.

Authors:  M A Sprangers; C E Schwartz
Journal:  Ann Oncol       Date:  1999-07       Impact factor: 32.976

2.  Self-reported sleep disturbances in employed women.

Authors:  K A Lee
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

3.  Studying cancer-related fatigue: report of the NCCN scientific research committee.

Authors:  Joanne E Mortimer; Andrea M Barsevick; Charles L Bennett; Ann M Berger; Charles Cleeland; Shannon R DeVader; Carmen Escalante; Jeffrey Gilreath; Arti Hurria; Tito R Mendoza; Hope S Rugo
Journal:  J Natl Compr Canc Netw       Date:  2010-12       Impact factor: 11.908

4.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

5.  Applications of health-related quality of life for guiding health care: advances in response shift research.

Authors:  Sara Ahmed; Carolyn Schwartz; Lena Ring; Mirjam A G Sprangers
Journal:  J Clin Epidemiol       Date:  2009-11       Impact factor: 6.437

6.  The measurement structure of the Center for Epidemiologic Studies Depression Scale.

Authors:  T J Sheehan; J Fifield; S Reisine; H Tennen
Journal:  J Pers Assess       Date:  1995-06

7.  Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis.

Authors:  Christine Miaskowski; Bruce A Cooper; Steven M Paul; Marylin Dodd; Kathryn Lee; Bradley E Aouizerat; Claudia West; Maria Cho; Alice Bank
Journal:  Oncol Nurs Forum       Date:  2006-09-01       Impact factor: 2.172

8.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases.

Authors:  R L Daut; C S Cleeland; R C Flanery
Journal:  Pain       Date:  1983-10       Impact factor: 6.961

Review 9.  Care for the cancer caregiver: a systematic review.

Authors:  Allison J Applebaum; William Breitbart
Journal:  Palliat Support Care       Date:  2012-10-10

10.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  18 in total

1.  Common and Distinct Characteristics Associated With Trajectories of Morning and Evening Energy in Oncology Patients Receiving Chemotherapy.

Authors:  Hamza Abid; Kord M Kober; Betty Smoot; Steven M Paul; Marilyn Hammer; Jon D Levine; Kathryn Lee; Fay Wright; Bruce A Cooper; Yvette P Conley; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-01-04       Impact factor: 3.612

2.  Cytokine Gene Polymorphisms Associated With Various Domains of Quality of Life in Women With Breast Cancer.

Authors:  Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-09-23       Impact factor: 3.612

3.  Perceived fatigue and energy are independent unipolar states: Supporting evidence.

Authors:  Bryan D Loy; Michelle H Cameron; Patrick J O'Connor
Journal:  Med Hypotheses       Date:  2018-02-19       Impact factor: 1.538

4.  Morning Fatigue Severity Profiles in Oncology Outpatients Receiving Chemotherapy.

Authors:  Fay Wright; Laura B Dunn; Steven M Paul; Yvette P Conley; Jon D Levine; Marilyn J Hammer; Bruce A Cooper; Christine Miaskowski; Kord M Kober
Journal:  Cancer Nurs       Date:  2019 Sep/Oct       Impact factor: 2.592

5.  Neuropsychological Symptoms and Intrusive Thoughts Are Associated With Worse Trajectories of Chemotherapy-Induced Nausea.

Authors:  Komal Singh; Steven M Paul; Kord M Kober; Yvette P Conley; Fay Wright; Jon D Levine; Paule V Joseph; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-11-02       Impact factor: 3.612

6.  Cytokine Genetic Variants and Health-Related Quality of Life in Crohn's Disease: An Exploratory Study.

Authors:  Mitchell R Knisely; Yvette P Conley; Eva Szigethy
Journal:  Biol Res Nurs       Date:  2019-07-04       Impact factor: 2.522

7.  Cytokine Gene Polymorphisms Associated With Symptom Clusters in Oncology Patients Undergoing Radiation Therapy.

Authors:  Christine Miaskowski; Yvette P Conley; Judy Mastick; Steven M Paul; Bruce A Cooper; Jon D Levine; Mitchell Knisely; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2017-08-08       Impact factor: 3.612

8.  Polymorphisms in Cytokine Genes Are Associated With Higher Levels of Fatigue and Lower Levels of Energy in Women After Breast Cancer Surgery.

Authors:  Kord M Kober; Betty Smoot; Steven M Paul; Bruce A Cooper; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2016-09-21       Impact factor: 3.612

9.  Characteristics Associated With Physical Function Trajectories in Older Adults With Cancer During Chemotherapy.

Authors:  Melisa L Wong; Steven M Paul; Judy Mastick; Christine Ritchie; Michael A Steinman; Louise C Walter; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2018-08-23       Impact factor: 3.612

10.  Age differences in fatigue, decrements in energy, and sleep disturbance in oncology patients receiving chemotherapy.

Authors:  Lindsey E Bischel; Christine Ritchie; Kord M Kober; Steven M Paul; Bruce A Cooper; Lee-May Chen; Jon D Levine; Marilyn Hammer; Fay Wright; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2016-07-15       Impact factor: 2.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.